Documentation for a New Cell Therapies Manufacturing Facility
A global biopharma company building a new cell therapies manufacturing facility lacked in-house expertise for 21 CFR 11-compliant IT documentation. Kalleid implemented a writing and review framework, trained multinational engineering teams, and managed document release through the QMS — eliminating the documentation bottleneck and keeping the facility on its go-live timeline.
Read More
